Chimerix (NASDAQ:CMRX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Chimerix (CMRX) operate in?

Chimerix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Chimerix Stock (NASDAQ: CMRX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	50.00 / 229.29K
Day Range	- - -
52 Wk Range	0.78 - 1.30
Market Cap	$84.25M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	58
Short Interest	2.14%
Days to Cover	7.9

Recent News

NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying

The Dow Jones closed lower by around 388 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank

The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the company’s Silicon Valley Bank.

Chris Katje

Sunrun Down Over 10% On Silicon Valley Bank Exposure: What Other Companies Are Exposed?

Shares of Sunrun Inc (NASDAQ: RUN), the largest residential solar developer in the U.S, fell by as much as 15% on Friday as a result of the news that Silicon Valley Bank has been closed by the

AJ Fabino

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Chimerix Inc

Sector

Health Care

Industry

Biotechnology

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Chimerix (CMRX) stock?

You can purchase shares of Chimerix (NASDAQ:CMRX) through any online brokerage.

View our list of the best stock brokerages

Who are Chimerix (CMRX) competitors?

Other companies in Chimerix’s space includes: Serina Therapeutics (AMEX:SER), Connect Biopharma Hldgs (NASDAQ:CNTB), T2 Biosystems (NASDAQ:TTOO), Eagle Pharmaceuticals (NASDAQ:EGRX) and Gritstone Bio (NASDAQ:GRTS).

What is the target price for Chimerix (CMRX) stock?

There is no analysis for Chimerix.

What is the forecast for Chimerix (CMRX) stock?

Chimerix has a consensus price target of $7.75.

Current stock price for Chimerix (CMRX)?

The stock price for Chimerix (NASDAQ: CMRX) is $0.94 last updated July 19, 2024 at 9:27 AM EDT.

Does Chimerix (CMRX) pay a dividend?

There are no upcoming dividends for Chimerix.

When is Chimerix (NASDAQ:CMRX) reporting earnings?

Chimerix’s Q2 earnings are confirmed for Monday, August 5, 2024.

Is Chimerix (CMRX) going to split?

There is no upcoming split for Chimerix.

What sector and industry does Chimerix (CMRX) operate in?

Chimerix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Chimerix

Chimerix (CMRX) Forecast